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Introduction
Oral lichen planus (OLP) is a chronic inflammatory 
mucosal disease of unknown origin which affects 
approximately 4% of the adult population, and 
more frequently affects middle-aged and elderly 
women.1,2 Lesions are usually bilateral and mainly 
affect the buccal mucosa, gingiva, and lateral side 
of the tongue.3 Clinically, OLP has a distinct morphol-
ogy with two typical forms: atrophic-erosive lesions 
with or without concomitant reticular lesions, and 
reticular and/or plaque lesions.4 A diagnosis of OLP 
is based on the presence of an epithelial-connective 
tissue interface band of infiltrating T lymphocytes, 
and the lesion is considered to be an autoimmune 
disorder mediated by T cells.5
Background/purpose: Oral lichen planus (OLP) is a chronic inflammatory disorder 
characterized by a T cell-mediated immune response against epithelial cells. Matrix 
metalloproteinases (MMPs) are an important group of zinc enzymes and are thought 
to play an important role in the degradation of components of the extracellular 
matrix. The aim of this study was to assess the expression of MMP-2 and MMP-9 in 
both tissue specimens and circulating plasma.
Materials and methods: Twelve cases of OLP were collected. In addition, six cases 
with chronic inflammation and six normal subjects were also recruited. Oral tissue 
specimens were collected for measurement of MMPs by immunohistochemistry, and 
sera prepared from peripheral blood were used for gelatin zymography to determine 
MMP levels in plasma.
Results: The level of MMP-2 in patients with OLP was significantly higher than that 
in the other two groups, both in tissues and sera (P < 0.0001). However, there was 
no difference in the expression of MMP-9 among these groups.
Conclusion: MMP-2 overexpression in OLP is consistent with its upregulation in periph-
eral serum. This result also indicates that MMP-2 might play a role in the pathogenesis 
of OLP.
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Usually, OLP has a chronic progression, and most 
cases exhibit inflammation. The levels of some 
molecules involved in mediating inflammatory pro-
cesses were reported to be increased in this dis-
ease.6 Among the effects of the inflammatory 
mediators, the induction of matrix metalloprotein-
ases (MMPs) has been demonstrated.7 MMPs are a 
large family of proteolytic enzymes, which are in-
volved in degrading many different components of 
the extracellular matrix. They are associated with 
normal tissue remodeling, embryonic development, 
wound healing, angiogenesis, bone resorption, and 
inflammation.8
Histopathologically, a dense subepithelial band-
like infiltration of lymphocytes and increased num-
bers of intraepithelial lymphocytes are found in 
OLP, with changes and disruption of the epithelial 
basement membrane.9 Basement membrane dam-
age, basal cell liquefaction, and tissue remodeling 
associated with OLP require degradation of the sur-
rounding extracellular matrix. In the MMP family, 
gelatinase (MMP-2 and MMP-9) cleaves denatured 
collagens (gelatins) and type IV collagen, the major 
component of basement membranes.10 Previous 
studies using immunohistochemistry showed that 
MMP-2 and MMP-3 were mainly found in OLP epi-
thelium, while MMP-9 staining was found in the 
inflammatory infiltrate.11
To the best of our knowledge, no one has eluci-
dated the circulating plasma expression of MMPs in 
OLP. There is no available information on the inter-
relationships of MMP-2 and MMP-9 expression in oral 
lesional sites and circulating plasma. Therefore, our 
aim was to explore the expression of MMP-2 and 
MMP-9 in both oral tissue specimens and sera from 
peripheral blood of OLP patients using immunohis-
tochemistry and gelatin zymography.
Materials and methods
Patient selection
Formalin-fixed, paraffin-embedded OLP specimens 
were obtained from 12 consecutive patients (9 fe-
males and 3 males) at the Department of Oral and 
Maxillofacial Surgery, Buddhist Dalin Tzu Chi Gen-
eral Hospital, Chiayi, Taiwan. Patients with a history 
of any systemic disease were excluded from the 
study. Their ages ranged from 28 to 83 years (mean, 
61.08 ± 15.6 years). The diagnosis of each lesion 
was confirmed by a histologic examination of he-
matoxylin and eosin-stained sections. The patho-
logic diagnosis of OLP was established as described 
by Krutchkoff et al.12 The types of OLP were sub-
classified into two clinical forms: reticular and/or 
plaque lesions (6 cases) and erosive lesions (6 cases). 
Normal controls (clinically normal oral mucosa) 
were obtained from six healthy volunteers (mean 
age, 32.66 ± 10.2 years; range, 21−58 years). Disease 
controls consisted of six specimens of oral chronic 
ulcer (ulceration persisting for more than 1 month) 
(mean age, 66.66 ± 4.3 years; range, 52−70 years). 
In addition, peripheral blood from eight OLP pa-
tients (four cases from each subgroup), four cases 
of chronic ulcer, and four cases of normal oral mu-
cosa were collected at the same time. Written con-
sent was obtained from all patients before taking 
specimens. The study protocol was approved by the 
Research Ethics Committee of our institution.
Immunohistochemistry
Immunohistochemical staining was performed using 
a peroxidase-labeled streptavidin-biotin technique.8 
Briefly, sections of 5 μm were deparaffinized and 
then heated in an autoclave for 40 minutes to 
retrieve the antigenicity before blocking with en-
dogenous peroxidase. Following treatment with 3% 
hydrogen peroxide in methanol for 10 minutes to 
quench endogenous peroxidase activity, sections 
were incubated with goat polyclonal immunoglob-
ulin G (IgG) anti-MMP-2 (sc-8835; 1:20 dilution; Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) and anti-
MMP-9 antibodies (sc-6840; 1:20 dilution; Santa 
Cruz Biotechnology), or leukocyte common anti-
gen, a specific antibody for lymphocytes (Dako, 
Carpinteria, CA, USA; 1:50 dilution), for 30 minutes. 
After washing in 10 mmol/L Tris-buffered saline, sec-
tions were treated with donkey anti-goat IgG-HRP 
(sc-2020; 1:100 dilution; Santa Cruz Biotechnology) 
for 30 minutes. Final products were visualized by a 
diaminobenzidine (DAB) substrate kit (Liquid DAB+ 
Substrate Chromogen System, code K3467; Dako) 
for 5 minutes. Sections were then counterstained 
with hematoxylin, mounted with mounting medium, 
and examined by light microscopy. To demonstrate 
the specificity of staining, negative controls were 
included, in which the primary antibody was re-
placed with phosphate-buffered saline. A reddish-
brown substrate in the cytoplasm indicated positive 
staining for MMP-2/MMP-9.
Each specimen was graded at 200× magnification 
as follows: +++, 50% to approximately 100%; ++, 
25% to approximately 50%; and +, < 25% of the pro-
portion of positively stained cells in tissue sections.
Gelatin zymography
Serum samples were analyzed for MMP-2/MMP-9 
with gelatin zymography as previously described.13 
Peripheral blood was first collected then centrifuged 
at 400g for 10 minutes at room temperature. The 
plasma and buffy coat layers were then separated. 
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An additional centrifugation at 1000g for 10 min-
utes was performed on the plasma fraction to 
remove remaining cellular debris and the plasma 
was then stored at −80ºC. For each serum sample, 
10 μg of total protein was loaded onto precast 
sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) containing 0.1% gelatin. After 
electrophoresis, the gels were washed in 2.5% Triton 
X-100 twice for 30 minutes to remove all sodium 
dodecyl sulfate. The gels were then incubated in 
50 mmol/L TRIS (pH 7.5), 5 mmol/L calcium chlo-
ride, and 1 mmol/L zinc chloride at 37ºC overnight. 
The gelatin cleavage rate from the photographed 
gels was analyzed with a densitometer (AlphaImager 
2000; Alpha Innotech, San Leandro, CA, USA).
Statistical analysis
The JMP Statistical Discovery Software version 
5.1.2 (SAS Institute, Cary, NC, USA) was used to 
analyze the data. Differences in immunohistochem-
ical expression between groups were analyzed using 
Fisher’s exact test. Gelatin zymography data were 
analyzed by one-way ANOVA. P < 0.05 was consid-
ered to be statistically significant.
Results
Histologic examination of all OLP specimens showed 
typical findings of this disease, including stratified 
epithelium, inflammatory subepithelial T lympho-
cyte infiltration and, occasionally, a sawtooth-like 
appearance of the epithelium. The infiltrate con-
sisted mainly of leucocytes, which were labeled with 
leukocyte common antigen (Fig. 1).
Immunohistochemistry results (Table 1) are shown 
in Fig. 2 for MMP-2 and Fig. 3 for MMP-9. Cells pos-
itively stained for MMP-2 were located at epithelial 
keratinocytes and fibroblasts, and lymphocytes of 
the subepithelial inflammatory infiltrate. MMP-9-
positive cells were located at epithelial keratino-
cytes and inflammatory infiltrate lymphocytes. There 
was no difference in MMP-2 expression between the 
reticular and erosive types of OLP. When all OLP 
patients were included as one group, the level of 
MMP-2 in OLP subjects was significantly higher than 
that in the other two groups (P < 0.0001). However, 
the percentage of positive staining for MMP-9 did not 
significantly differ among the groups (P = 0.5302).
MMP-2 and MMP-9 activities in sera were assayed 
by gelatin zymography. The presence of MMP-2 and 
MMP-9 was indicated as bands of 72 and 92 kDa, 
respectively, as shown in Fig. 4. The quantitative 
measurements by the AlphaImager 2000 densitom-
eter are shown in Fig. 5. The density of MMP-2 was 
significantly elevated in the two OLP subgroups, 
compared with those of the chronic ulcer group 
and normal control groups (P < 0.0001). The levels 
of MMP-9 in sera, however, did not significantly 
differ between groups (P = 0.1417).
Discussion
The first study investigating the relation of lichen 
planus and MMPs was reported by Giannelli et al.14 
Fig. 1 Leukocytes in an inflamed subepithelial band of an 
oral lichen planus lesion labeled by leukocyte common 
antigen using a peroxidase-labeled streptavidin-biotin 
technique (original magnification ×200).
Table 1. Expression of matrix metalloproteinase (MMP)-2/MMP-9 in oral lichen planus (OLP) and control groups
 MMP-2 expression* MMP-9 expression*
Study group
 + ++ +++ 
P
 + ++ +++ 
P
EOLP 0 0 6  2 3 1
OLP 0 0 6  0 5 1
Chronic inflammation 0 5 1  3 2 1
NOM 6 0 0 < 0.0001† 1 3 2 0.5302†
*< 25% (+), 26−50% (++), 51−100% (+++) of the proportion of positively stained cells in tissue sections; †Fisher’s exact test compar-
ing the EOLP and OLP groups combined, the chronic inflammation group and the NOM group. EOLP = erosive oral lichen planus; 
OLP = reticular and/or plaque oral lichen planus; NOM = normal oral mucosa.
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Fig. 2 Immunohistochemical reactivity for matrix metalloproteinase (MMP)-2 (original magnification ×200). (A) The degree 
of immunoreactivity to MMP-2 in normal oral mucosa was < 25%. (B) The degree of staining in chronic inflammation 
was 25−50%. The staining pattern of MMP-2 was similar (> 50%) among the (C) reticular and/or plaque lesions and 
(D) erosive lesions.
A B
C D
Fig. 3 Immunohistochemical reactivity for matrix metalloproteinase (MMP)-9 (original magnification ×200). (A) Expression 
of MMP-9 in normal oral mucosa. (B) Expression of MMP-9 in chronic inflammation. (C) Expression of MMP-9 in reticular 
oral lichen planus (OLP) (D) Expression of MMP-9 in erosive OLP. The intensity of immunostaining of MMP-9 varied among 
the four groups, and most of the positively stained cells were located at the subepithelial infiltrating lymphocytes.
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They reported increased MMP-2 expression in acute 
stages of lichen planus and suggested that an 
altered balance between MMP-2 and tissue inhibi-
tors of metalloproteinase-2 may play a role in the 
destruction of basement membrane. Zhou et al.11 
also reported MMP-2 expression in OLP epithelium. 
They suggested that MMPs may act synergistically 
to degrade the epithelial basement membrane in 
OLP. Here, we first demonstrated that MMP-2 
overexpression in OLP lesions was due to MMP-2 
upregulation in circulating plasma. Extracellular 
proteolysis is generally required for tissue injury in 
autoimmune and inflammatory diseases, and the 
plasminogen/plasmin system and MMPs cooperate 
in such pro cesses.15 Thus, basement membrane de-
gradation during OLP progression may be mediated 
by MMPs.
A previous study showed that elevated expression 
of inflammatory cytokines, such as interleukin-1α 
and tumor necrosis factor (TNF)-α, was found in 
OLP.16 Other studies also showed that MMP synthe-
sis is triggered by tumor necrosis factor-α and 
interleukin-1α.17,18 Our results indicated that MMP-2 
was upregulated in both oral specimens and cir-
culating plasma of OLP patients. MMP-2 overex-
pression in OLP may be related to inflammatory 
cytokines. The phenomenon of MMP-2 upregulation 
in circulation also implies that OLP might be a 
systemic disorder.
Kim et al.19 reported that under upregulation by 
bone morphogenetic protein (BMP)-4, both MMP-1 
and MMP-3 expression in OLP may induce epithelial 
cells acantholysis and lead to erosive changes. We 
found that the MMP-2 expression pattern in OLP did 
not significantly differ between reticular and plaque 
lesions, and erosive lesions. Thus, the expression of 
MMP-1 and MMP-3, but not MMP-2 or MMP-9, may be 
important in determining the phenotype of OLP.
In our clinical experience, some OLP cases 
were diagnosed by their clinical characterization 
but failed to match the histopathologic diagnostic 
criteria. Their pathologic diagnoses were often 
described as a “chronic ulcer” or “chronic inflam-
mation”. Our study revealed that the MMP-2 level in 
OLP was significantly higher than that in a chronic 
ulcer. This finding might provide a diagnostic tool 
for the differential diagnosis between OLP and 
chronic ulceration, regardless of whether immuno-
histochemistry or peripheral serum analysis is used.
In conclusion, we have demonstrated that MMP-2 
overexpression in OLP lesions was consistent with 
MMP-2 upregulation in sera. The MMP-2 level of 
OLP subjects was significantly higher than that of 
patients with chronic ulcers and normal controls, 
not only in lesional sites but also in the circulation. 
Determination of the MMP-2 level in oral specimens 
and peripheral blood can be used as a tool for the 
differential diagnosis between OLP and chronic 
ulcers. This result also implies that upregulation of 
MMP-2 might play an important role in the patho-
genesis of OLP.
92 kDa MMP-9
72 kDa MMP-2
Erosive OLP Reticular OLP Chronic ulcer Control
Fig. 4 Gelatin zymogram of matrix metalloproteinase (MMP). Gelatinolytic activity and molecular weight positions 
of MMP-2 (72 kDa) and MMP-9 (92 kDa) activities are indicated. OLP = oral lichen planus.
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Fig. 5 Optical density values of matrix metalloprotein-
ase (MMP)-2 were calculated from their gelatinolytic 
activities using an AlphaImager 2000 densitometer. The 
density of MMP-2 was significantly elevated in the two 
oral lichen planus (OLP) subgroups, compared with those 
of the chronic ulcer and control groups. *Significantly dif-
fers from the control value, at P < 0.05. EOLP = erosive 
oral lichen planus.
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